HCA Healthcare stock faces tougher 2027 as coverage losses mount

HCA Healthcare is heading into a more difficult earnings environment as patients lose Affordable Care Act coverage and Medicaid funding comes under pressure. Reuters reported on Thursday, November 5, that major U.S. hospital operators were seeing steady admissions while rising uninsured care squeezed operating margins.

The shift in coverage is central to the outlook. Reuters said the expiration of pandemic-era federal subsidies on January 1, 2026, pushed premiums higher and contributed to more than 3 million people dropping their plans. HCA Healthcare estimated that the loss of those subsidies could reduce its income by up to 1.2 billion US dollars in 2026.

Uninsured care weighs on margins

HCA Healthcare, Tenet Healthcare and Universal Health Services reported year-over-year declines of 17% to 19% in third-quarter ACA exchange volumes, according to Reuters. Patients who lost coverage largely shifted to self-pay, leaving hospitals to absorb more of the cost of emergency and other treatment.

The pressure is significant because uninsured emergency care often generates little or no payment. Reuters cited Jefferies analyst Brian Tanquilut, who described those cases as effectively a write-off. J.P. Morgan analysts expect declining exchange enrollment to create a low- to mid-single-digit drag on hospital profit growth in 2027.

Medicaid adds a second headwind

HCA expects net benefits from Medicaid supplemental payments to decline by 550 million to 650 million US dollars in 2027, Reuters reported. The reduction follows a period in which supplemental payments supported the companies' results, making the coming comparison more demanding even if patient volumes remain firm.

The longer-term risk is tied to further reimbursement changes. Starting in 2027, certain working-age Medicaid adults will face work or community-service requirements to retain coverage. Reuters said the larger financial risk begins in 2028, when certain supplemental Medicaid payments are scheduled to be reduced by 10 percentage points annually.

For HCA Healthcare, the volume picture provides a counterweight to the payer pressure. The company operates in a market supported by an aging population and continued demand for medical care. That demand can support revenue growth, but it does not fully offset the margin effect when patients move from commercial coverage to uninsured treatment.

Investors weigh demand against policy

HCA Healthcare stock traded at 453.60 euros on Lang & Schwarz at 13:25 CET on Friday, November 13, 2026. The quote is a current trading indication and is not accompanied here by a verified Xetra comparison.

For investors, the key issue is whether volume growth, operating efficiencies and hospital demand can offset weaker payer economics. Reuters cited Morningstar analyst Julie Utterback as saying that Medicaid patients generate low profit margins, limiting the direct revenue effect of work requirements but leaving hospitals exposed to broader reimbursement changes.

The S&P 500 provides the broader U.S. equity-market context for healthcare stocks: Current market context.

Further coverage of the company, its reimbursement outlook and HCA Healthcare stock is available here: More news and analyses on HCA Healthcare stock.

Key facts